Search results
Q2 2024 EPS Estimates for Amicus Therapeutics, Inc. Increased by Zacks Research (NASDAQ:FOLD)
ETF DAILY NEWS· 18 hours agoAmicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) – Research analysts at Zacks Research raised their Q2 2024 EPS estimates for Amicus Therapeutics in a report issued on ...
Rise and fall: Two Mass. IPOs show drastic difference in investor response - Boston Business Journal
The Business Journals· 1 hour agoBurlington-based Fractyl Health raised $110 million in its IPO in January after pricing its shares...
Alvotech (NASDAQ:ALVO) Short Interest Update
ETF DAILY NEWS· 14 hours agoAlvotech (NASDAQ:ALVO – Get Free Report) was the recipient of a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling ...
ProQR Therapeutics (NASDAQ:PRQR) Stock Rating Upgraded by StockNews.com
ETF DAILY NEWS· 15 hours agoStockNews.com upgraded shares of ProQR Therapeutics (NASDAQ:PRQR – Free Report) from a sell rating to a hold rating in a research note released on Thursday. Other equities ...
3 Reasons to Buy Moderna Stock
Motley Fool via Yahoo Finance· 6 days agoMerck is one of the leading oncology-focused drugmakers in the world, largely thanks to Keytruda, a medicine that has earned dozens of approvals for...
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Motley Fool via Yahoo Finance· 6 days agoHere's why they picked Gilead Sciences (NASDAQ: GILD), Organon (NYSE: OGN), and Pfizer (NYSE: PFE)....
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Morningstar· 1 day agoCAMBRIDGE, MA / ACCESSWIRE / June 13, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that its Phase 3 trial of mRNA-1283, an investigational next-generation COVID-19 vaccine ...
Supreme Court's Thomas questions ability of groups to challenge US laws By Reuters
Investing.com· 24 hours agoThomas laid out his position in an opinion that concurred with the Supreme Court's 9-0 ruling...
RBC Capital ups Amgen shares target, cites cardiometabolic strategy and MariTide By Investing.com
Investing.com· 6 hours agoOn Friday, RBC (TSX:RY) Capital Markets adjusted its outlook on Amgen Inc . The firm's decision...
CureVac (NASDAQ:CVAC) Shares Down 4.8%
ETF DAILY NEWS· 6 days agoShares of CureVac (NASDAQ:CVAC – Get Free Report) traded down 4.8% during trading on Friday . The company traded as low as $4.67 and last traded at $4.75. 115,327 shares traded ...
